Quantitative measurement of anti-TSH receptor antibodies is useful for the evaluation of treatment effect.
暂无分享,去创建一个
A. Miyauchi | S. Morita | S. Fukata | N. Amino | S. Kubota
[1] A. Pinchera,et al. Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer. , 2002, The Journal of clinical endocrinology and metabolism.
[2] W. Scherbaum,et al. Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation. , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[3] C. Chapman,et al. Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. , 1999, Clinical chemistry.
[4] K. Usadel,et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. , 1999, The Journal of clinical endocrinology and metabolism.
[5] R. Carson,et al. Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography. , 1992, The Journal of clinical investigation.
[6] V. Marks,et al. INAPPROPRIATELY ELEVATED PLASMA INSULIN‐LIKE GROWTH FACTOR II IN RELATION TO SUPPRESSED INSULIN‐LIKE GROWTH FACTOR I IN THE DIAGNOSIS OF NON‐ISLET CELL TUMOUR HYPOGLYCAEMIA , 1990, Clinical endocrinology.
[7] N. Amino,et al. On standardization of the radioreceptor assay for anti-thyrotropin receptor antibody. , 1988, Clinical chemistry.
[8] D. Schoenfeld,et al. A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma , 1985, Cancer.
[9] B. Smith,et al. THYROID-STIMULATING IMMUNOGLOBULINS IN GRAVES' DISEASE , 1974 .